Genetics
Neurological Genetic Tests in Dubai & UAE
Investigations in this area, with the specimen type, turnaround time and listed price for each option — so you and your clinician can compare before you book.
3 min read
- Quality-controlled laboratory
- Home collection across the UAE
- Confidential handling of results
Compare options
Neurological Genetic investigations
All 49 investigations in this category are listed below.
| Test | What it measures | Specimen | Turnaround | Price | Book |
|---|---|---|---|---|---|
| AFG3L2 Gene Spastic Ataxia Type 5, Autosomal Recessive Genetic Test TEST-5711 LOINC 81263-4 | This test identifies pathogenic variants in the AFG3L2 gene associated with autosomal recessive spastic ataxia type 5. | Peripheral Whole Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
| ANO3 Gene (DYT24) Genetic Test TEST-4204 LOINC 102022-8 | This test evaluates the ANO3 gene for pathogenic variants associated with autosomal dominant dystonia type 24. | Whole blood (2–5 mL EDTA), extracted DNA (≥1 µg), or FTA card (3 dried blood spots) | 3–4 weeks (expedited 2-week option available) | 2,800.00 AED | Details |
| ARHGEF9 Gene-Related Hyperekplexia & EIEE8 Genetic Test TEST-4618 LOINC 21636-6 | This genetic test identifies pathogenic variants in the ARHGEF9 gene associated with hereditary hyperekplexia and early infantile epileptic encephalop... | Whole Blood or Dried Blood Spot (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| ARX Gene Partington Syndrome Genetic Test TEST-5541 LOINC 10386-3 | This test sequences the ARX gene to detect pathogenic variants associated with Partington syndrome. | Peripheral Whole Blood (3-5 mL in EDTA) or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| ATXN7 Gene (Spinocerebellar Ataxia Type 7) Genetic Test TEST-5800 LOINC 92747-7 | This test detects CAG repeat expansions in the ATXN7 gene, which are the cause of Spinocerebellar Ataxia Type 7. | Peripheral whole blood (3–5 mL in EDTA tube) | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| CACNA1A Gene Analysis (Familial Hemiplegic Migraine Type 1) Test TEST-4472 LOINC 94244-1 | This test identifies pathogenic variants in the CACNA1A gene associated with Familial Hemiplegic Migraine Type 1 (FHM1). It uses Next Generation Seque... | Peripheral Whole Blood or Dried Blood Spot | 3–4 Weeks | 2,800.00 AED | Details |
| CACNA1A Gene Spinocerebellar Ataxia Type 6 (SCA6) Genetic Test TEST-5896 LOINC 82996-8 | This test identifies pathogenic variants within the CACNA1A gene, confirming a diagnosis of autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6). | Whole Blood, Extracted DNA, or One Drop Blood on FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| CDKL5 Deficiency Disorder (Angelman‑like Syndrome) Genetic Test TEST-3837 LOINC 94121-4 | This test identifies genetic variants in the CDKL5 gene associated with early-onset epileptic encephalopathy resembling Angelman syndrome. | Whole Blood (peripheral) / Dried Blood Spot on FTA Card | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| CELF6 Gene Genetic Test for Autism Spectrum Disorder TEST-3915 LOINC 94473-2 | This test identifies pathogenic variants in the CELF6 gene associated with Autism Spectrum Disorder (ASD). | Peripheral Whole Blood | 3 – 4 Weeks | 2,800.00 AED | Details |
| CLP1 Gene Pontocerebellar Hypoplasia Type 10 Genetic Testing Test TEST-5603 LOINC 21636-6 | This genetic test identifies pathogenic variants in the CLP1 gene associated with pontocerebellar hypoplasia type 10. | Whole blood (EDTA), or single drop on FTA card | 3–4 weeks | 2,800.00 AED | Details |
| COL6A6 Gene Myopathy (COL6A6-Related) Genetic Test TEST-5336 LOINC 81214-2 | This test analyzes the COL6A6 gene for pathogenic variants associated with congenital myopathies and muscular dystrophies. | Peripheral whole blood (EDTA tube) | 3–4 weeks | 2,800.00 AED | Details |
| CPT1C Gene (SPG73) Genetic Test TEST-5712 LOINC 21665-5 | This test identifies pathogenic variants in the CPT1C gene associated with Hereditary Spastic Paraplegia Type 73 (SPG73). | Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card) | 3–4 weeks (expedited available) | 2,800.00 AED | Details |
| CWF19L1 Gene Spinocerebellar Ataxia Type 17 (Autosomal Recessive) Genetic Test TEST-5760 LOINC 82154-2 | This test identifies pathogenic variants within the CWF19L1 gene associated with autosomal recessive spinocerebellar ataxia type 17 (SCA17). | Whole blood (EDTA), saliva, or buccal swab | 3–4 weeks | 2,800.00 AED | Details |
| DARS2 Gene Leukoencephalopathy with Brainstem & Spinal Cord Involvement & Lactate Elevation (LBSL) Genetic Test TEST-4689 LOINC 81369-8 | This genetic test identifies pathogenic variants in the DARS2 gene, confirming a diagnosis of LBSL. | Peripheral Whole Blood (EDTA) or Extracted DNA | 3–4 weeks | 2,800.00 AED | Details |
| DCX Gene Analysis (X-Linked Lissencephaly & Subcortical Band Heterotopia) Genetic Test TEST-4751 LOINC 82272-8 | This test analyzes the DCX gene to identify mutations associated with X-linked lissencephaly and subcortical band heterotopia. | Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card) | 3-4 Weeks | 2,800.00 AED | Details |
| DRD2 Gene Sequencing for Myoclonic Dystonia Test TEST-5222 LOINC 50286-7 | This test evaluates the DRD2 gene for pathogenic variants associated with myoclonic dystonia (DYT11). | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| EGR2 Gene CMT4E Next‑Generation Sequencing Genetic Test TEST-4048 LOINC 94409-2 | This genetic test identifies pathogenic variants in the EGR2 gene associated with Charcot‑Marie‑Tooth disease type 4E. | Peripheral whole blood, extracted DNA, or FTA card | 3–4 Weeks | 2,800.00 AED | Details |
| FIG4 Gene CMT4J (Charcot-Marie-Tooth Disease Type 4J) Genetic Test TEST-4058 LOINC 21684-6 | This test detects pathogenic variants in the FIG4 gene associated with Charcot-Marie-Tooth disease type 4J. | Whole Blood (EDTA) or Dried Blood Spot (FTA Card) | 3–4 weeks | 2,800.00 AED | Details |
| GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test TEST-4398 LOINC 53429-6 | This genetic test analyzes the GRIN2A gene for pathogenic variants associated with epilepsy and neurodevelopmental defects. | Peripheral whole blood | 3 to 4 weeks | 2,800.00 AED | Details |
| HOXB1 Gene Facial Paresis Type 3 Genetic Test TEST-4469 LOINC 89724-1 | This test analyzes the HOXB1 gene for pathogenic variants associated with hereditary congenital facial palsy type 3. | Peripheral Whole Blood | 3–4 weeks | 2,800.00 AED | Details |
| HSPD1 Gene SPG13 Genetic Test TEST-5629 LOINC 86254-4 | This genetic test identifies pathogenic variants in the HSPD1 gene, confirming a diagnosis of Hereditary Spastic Paraplegia type 13 (SPG13). | Peripheral Whole Blood or DNA FTA Card | 3 to 4 weeks | 2,800.00 AED | Details |
| KIF1A Gene SPG30 Genetic Test TEST-5743 LOINC 21634-2 | This test sequences the entire KIF1A gene to detect mutations associated with hereditary spastic paraplegia type 30 (SPG30). It identifies single nucl... | Whole Blood (Peripheral) | 3–4 Weeks | 2,800.00 AED | Details |
| MFN2 Gene CMT2A2 Next‑Generation Sequencing (NGS) Genetic Test TEST-4064 LOINC 94122-5 | This test identifies pathogenic variants in the MFN2 gene associated with Charcot-Marie-Tooth disease type 2A2. | Whole blood / Extracted DNA / FTA Card | 14–21 working days (expedited available) | 2,800.00 AED | Details |
| NDE1 Gene Lissencephaly Type 4 with Microcephaly Genetic Test TEST-4842 LOINC 100116-6 | This test identifies mutations in the NDE1 gene associated with lissencephaly type 4 with microcephaly. | Peripheral whole blood (4 mL in EDTA tube) or extracted genomic DNA | 3–4 weeks (expedited 2–3 weeks available for urgent cases) | 2,800.00 AED | Details |
| NDUFAF3 Gene Leigh Syndrome Genetic Test TEST-4720 LOINC 94038-6 | This test identifies pathogenic variants in the NDUFAF3 gene, which are associated with Leigh syndrome, a severe inherited mitochondrial neurological... | Whole blood (3–5 mL in EDTA tube), dried blood spot on FTA card, or previously extracted DNA | 3–4 weeks | 2,800.00 AED | Details |
| NDUFS4 Gene Leigh Syndrome Genetic Test TEST-4638 LOINC 82566-0 | This test identifies pathogenic variants in the NDUFS4 gene, a nuclear-encoded cause of Leigh syndrome. | Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card | 3 to 4 Weeks | 2,800.00 AED | Details |
| NDUFS7 Gene (Leigh Syndrome) Genetic Testing via NGS Test TEST-4728 LOINC 81269-8 | This test identifies pathogenic variants in the NDUFS7 gene associated with Leigh syndrome using Next-Generation Sequencing. | Whole blood (peripheral venous) or extracted DNA | 21–28 Days | 2,800.00 AED | Details |
| NGEF Gene Neurodevelopmental Disorder Genetic Test TEST-5329 LOINC 89578-0 | This genetic test screens for pathogenic variants in the NGEF gene linked to neurodevelopmental disorders. | Whole Blood, Extracted DNA, or Dried Blood Spot (FTA Card) | 3 to 4 Weeks | 2,800.00 AED | Details |
| PINK1 Gene (PARK6) Parkinson Genetic Test TEST-5523 LOINC 82321-0 | This test evaluates the PINK1 gene for mutations associated with early-onset Parkinson's disease. | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| PRRT2 Gene Sequencing Test for Familial Infantile Convulsions with Paroxysmal Choreoathetosis (NGS) TEST-4144 LOINC 81607-8 | This test identifies mutations in the PRRT2 gene associated with specific neurological disorders. | Peripheral Blood | 3 to 4 Weeks | 2,800.00 AED | Details |
| RAB7A Gene CMT2B Genetic Test TEST-4010 LOINC 81321-3 | This test detects pathogenic variants in the RAB7A gene associated with Charcot-Marie-Tooth disease type 2B. | Peripheral Whole Blood (EDTA) or DNA FTA Card | 21–28 Business Days | 2,800.00 AED | Details |
| REEP1 Gene (SPG31) Genetic Test TEST-5650 LOINC 81262-2 | This diagnostic test evaluates the REEP1 gene for pathogenic variants associated with hereditary spastic paraplegia type 31 (SPG31). | Whole blood (2–3 mL EDTA), extracted DNA, or FTA card | 3–4 weeks | 2,800.00 AED | Details |
| RNF170 Gene Ataxia Sensory Type 1 Autosomal Dominant Genetic Test TEST-3830 LOINC 94233-3 | This test identifies pathogenic variants in the RNF170 gene associated with Autosomal Dominant Sensory Ataxia Type 1. | Peripheral Whole Blood or FTA Card Sample | 3 to 4 Weeks | 2,800.00 AED | Details |
| SCN10A Gene Episodic Pain Syndrome Type 2, Familial Test TEST-4460 LOINC 82939-0 | This test evaluates the SCN10A gene for pathogenic variants associated with familial episodic pain syndrome type 2 (FEPS2). It uses next-generation se... | Peripheral whole blood (EDTA), extracted DNA, or FTA card | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| SCN11A Gene Episodic Pain Syndrome Type 3 Familial Genetic Test TEST-4395 LOINC 81223-8 | This test identifies pathogenic variants in the SCN11A gene associated with familial episodic pain syndrome type 3. | Peripheral whole blood, extracted DNA, or dried blood spot (FTA card) | 3–4 Weeks (expedited 2‑week option available) | 2,800.00 AED | Details |
| SCN1A Gene (Early Infantile Epileptic Encephalopathy Type 6) Genetic Test TEST-4282 LOINC 21680-2 | This test evaluates the SCN1A gene for pathogenic variants associated with early infantile epileptic encephalopathy type 6 (Dravet syndrome). | Blood (EDTA), Extracted DNA, or FTA Card | 3–4 Weeks (STAT option available) | 2,800.00 AED | Details |
| SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test TEST-4477 LOINC 21636-6 | This test evaluates the SCN1A gene for pathogenic variants associated with Familial Hemiplegic Migraine Type 3. | Peripheral Whole Blood (EDTA) | 3–4 Weeks | 2,800.00 AED | Details |
| SCN4A Gene Potassium-Aggravated Myotonia Genetic Test TEST-5521 LOINC 81306-2 | This test identifies mutations in the SCN4A gene associated with potassium-aggravated myotonia. | Peripheral whole blood | 3–4 weeks (standard) / 2 weeks (expedited) | 2,800.00 AED | Details |
| SLC12A6 Genetic Test TEST-3716 LOINC 8251-1 | This test evaluates the entire SLC12A6 gene for pathogenic variants associated with Andermann syndrome. | Peripheral whole blood, extracted DNA, or dried blood spot | 25–28 calendar days | 2,800.00 AED | Details |
| SLC25A22 Gene Early Infantile Epileptic Encephalopathy Type 3 Genetic Test TEST-4317 LOINC 21656-5 | This genetic test detects pathogenic variants in the SLC25A22 gene associated with Early Infantile Epileptic Encephalopathy Type 3. | Peripheral whole blood | 3–4 weeks | 2,800.00 AED | Details |
| SOD1 Gene Amyotrophic Lateral Sclerosis Type 1 (ALS1) Genetic Test TEST-3767 LOINC 69548-9 | This genetic test evaluates the SOD1 gene for variants associated with Amyotrophic Lateral Sclerosis Type 1 (ALS1). | Whole Blood (EDTA), Extracted DNA, or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| SPR Gene Dystonia (DOPA‑Responsive, Autosomal Recessive) Genetic Test (NGS) TEST-4235 LOINC 94309-9 | This test identifies pathogenic variants in the SPR gene associated with DOPA-responsive dystonia, an autosomal recessive disorder. | Peripheral Whole Blood | 3–4 Weeks | 2,800.00 AED | Details |
| TARDBP Gene Frontotemporal Dementia Genetic Test TEST-4148 LOINC 92811-1 | This genetic test evaluates the TARDBP gene for pathogenic variants associated with frontotemporal dementia and amyotrophic lateral sclerosis. | Whole Blood (venous), Extracted DNA, or FTA Card | 3–4 Weeks | 2,800.00 AED | Details |
| TBC1D24 Gene (EIEE16) Next-Generation Sequencing DNA Test TEST-4236 LOINC 21649-1 | This test identifies pathogenic variants in the TBC1D24 gene associated with Early Infantile Epileptic Encephalopathy Type 16 (EIEE16), a severe neona... | Peripheral whole blood (EDTA tube) or FTA dried blood spot card | 3–4 weeks | 2,800.00 AED | Details |
| TECPR2 Gene SPG49 Genetic Test TEST-5672 LOINC 69548-6 | This test detects pathogenic variants in the TECPR2 gene to diagnose autosomal recessive spastic paraplegia type 49 (SPG49). | Whole blood, extracted DNA, or dried blood spot (FTA card) | 3–4 weeks from sample receipt | 2,800.00 AED | Details |
| USP8 Gene NGS Test for SPG59 (Hereditary Spastic Paraplegia Type 59) TEST-5789 LOINC 21636-6 | This diagnostic test evaluates the USP8 gene for variants associated with Hereditary Spastic Paraplegia Type 59 (SPG59). | Whole Blood (EDTA) or DNA (extracted) | 21–28 days from sample receipt | 2,800.00 AED | Details |
| WASHC5 Gene (SPG8) Genetic Test (NGS) TEST-5818 LOINC 81246-7 | This test evaluates the entire coding sequence of the WASHC5 gene for pathogenic variants associated with Hereditary Spastic Paraplegia type 8 (SPG8). | Whole Blood, Extracted DNA, or FTA Card (Peripheral Blood) | 3–4 Weeks | 2,800.00 AED | Details |
| WWOX Gene Spinocerebellar Ataxia Type 12, Autosomal Recessive Next‑Generation Sequencing (NGS) Genetic Test TEST-5750 LOINC 81658-3 | This genetic test analyzes the WWOX gene to detect pathogenic variants associated with autosomal recessive spinocerebellar ataxia type 12 (SCAR12). | Peripheral Whole Blood, Serum, or Plasma | 3-4 weeks | 2,800.00 AED | Details |
| ZFYVE27 Gene SPG33 Genetic Test TEST-5748 LOINC 94719-4 | This test identifies pathogenic variants within the ZFYVE27 gene associated with Hereditary Spastic Paraplegia type 33 (SPG33). | Peripheral whole blood (3–5 mL in EDTA tube), Extracted DNA (2 µg minimum, >50 ng/µL), or One Drop Blood on FTA Card. | 3 to 4 weeks | 2,800.00 AED | Details |
Clinical overview
About Neurological Genetic
Pinpointing the exact hereditary cause of a progressive movement disorder, severe neuropathy, or early-onset cognitive decline is essential for unlocking the most effective neurological care available. As a highly focused diagnostic tool in our Molecular Genetics department, Neurological Genetic testing specifically targets the exact DNA mutations responsible for your family's unique neurological challenges. By leveraging advanced sequencing technology, this precise genomic screening confirms conditions like inherited ataxias or early-onset Alzheimer's, providing the critical data necessary to assess carrier status, evaluate risks for future children, and safely guide tailored neurological interventions. Highly regarded for specialized diagnostic excellence among the best diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical precision, and remarkably fast turnaround times. Take control of your long-term brain health—schedule your neurological genetic testing in UAE, coordinate a comfortable home sample collection, or consult our expert medical professionals.
Before your appointment
Preparation & sample collection
Follow the instructions you are given
Fasting, timing and medicine restrictions differ between investigations. The instructions for your specific request are confirmed when you book.
Bring your identification
A valid photo ID is required at collection so that your sample is matched correctly to your record.
Tell us about medicines
Prescription medicines, supplements and recent procedures can affect how an investigation is scheduled or interpreted — please mention them.
Ask before collection
If anything about preparation is unclear, contact us before your appointment. Preparation errors can affect reporting times.
Patient information
Frequently asked questions
Practical answers about Neurological Genetic testing at DNA Labs UAE. This information is general and does not replace advice from your treating clinician.
How do I choose the right Neurological Genetic test?
The correct investigation depends on what your clinician is trying to establish. Review the specimen type and turnaround time below, then confirm the choice with your treating doctor before booking.
What specimen is required?
Specimen requirements are listed for each investigation. If a request involves more than one sample type, our team will confirm what is needed at the time of booking.
Do you offer home sample collection in Dubai and the UAE?
Yes. Home collection can be arranged across Dubai and the wider UAE. Availability and appointment windows vary by location, so please confirm when you book.
How long do results take?
Turnaround depends on the investigation and the method used. The expected reporting time is confirmed with you before collection.
Is there anything I need to do before sample collection?
Some investigations require fasting, a specific collection time, or avoiding certain medicines or activities. Preparation details are shared when you book — please follow them and ask if anything is unclear.
How will I receive my report?
Reports are issued as secure digital documents and can be shared with your referring clinician on request. Please review results with a qualified clinician who can interpret them in context.
About this clinical information
The information on this Neurological Genetic page describes laboratory investigations in general terms. It is written to help you understand what an investigation involves — it is not a diagnosis and it is not a substitute for advice from your treating clinician.
- Investigation names, specimen types and listed prices are reviewed against laboratory records.
- Preparation guidance is indicative — confirm test-specific instructions before collection.
- Content is updated when investigations, methods or reporting formats change.
- Results are released to the patient and, on request, shared with the referring clinician.
Medical disclaimer: This page is for general information and education only. It is not medical advice, diagnosis or treatment, and it does not replace a consultation with a qualified healthcare professional. Always seek the advice of your doctor or another qualified provider with any questions about a medical condition or before ordering a test.
We're here to help
Need help choosing a Neurological Genetic test?
Tell us what your clinician has requested and we'll confirm availability, price, preparation and the most convenient collection option — including home collection in Dubai and across the UAE.
- Home collection available across the UAE
- Digital reports delivered securely
- Confidential handling of every request
Related areas